RhumbLine Advisers’s Telix Pharmaceuticals Limited American Depositary Shares TLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$19.2K	Buy	1,187 +41	+4%	+$663	﹤0.01%	3800
2025 Q1	$19.2K	Buy	+1,146	New	+$19.2K	﹤0.01%	3749